The potential of Ang-2 as a prognosis predictor is shown for a broad range of therapeutic strategies and HCC stages, ranging from surgical approaches in early HCC to systemic treatment in advanced HCC. Here, ANGPT2 is linked to hepatocellular carcinoma.